Advertisement

Index by author

April 01, 1993; Volume 265,Issue 1

A

  1. Alhaider, A A

    1. Differential roles of 5-hydroxytryptamine1A and 5-hydroxytryptamine1B receptor subtypes in modulating spinal nociceptive transmission in mice.
      A A Alhaider and G L Wilcox
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 378-385;

B

  1. Bachoo, M

    1. Mechanism of the bradycardia produced in the cat by the anticholinesterase neostigmine.
      S B Backman, M Bachoo and C Polosa
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 194-200;

  2. Backman, S B

    1. Mechanism of the bradycardia produced in the cat by the anticholinesterase neostigmine.
      S B Backman, M Bachoo and C Polosa
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 194-200;

  3. Bals-Kubik, R

    1. Examination of the neurochemical substrates mediating the motivational effects of opioids: role of the mesolimbic dopamine system and D-1 vs. D-2 dopamine receptors.
      T S Shippenberg, R Bals-Kubik and A Herz
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 53-59;

  4. Baraban, S C

    1. Respiratory control of sympathetic nerve activity during naloxone-precipitated morphine withdrawal in rats.
      S C Baraban, R L Stornetta and P G Guyenet
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 89-95;

  5. Barrett, R J

    1. In vitro and in vivo pharmacological characterization of N6-cyclopentyl-9-methyladenine (N-0840): a selective, orally active A1 adenosine receptor antagonist.
      R J Barrett, J M May, P L Martin and J R Miller
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 227-236;

  6. Beaune, P

    1. Metabolic activation of the nitroaromatic antiandrogen flutamide by rat and human cytochromes P-450, including forms belonging to the 3A and 1A subfamilies.
      A Berson, C Wolf, C Chachaty, C Fisch, D Fau, D Eugene, J Loeper, J C Gauthier, P Beaune and D Pompon
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 366-372;

  7. Becker, A

    1. Leukotriene generation and metabolism in dogs: inhibition of biosynthesis by MK-0591.
      P Tagari, A Becker, C Brideau, R Frenette, V Sadl, E Thomas, P Vickers and A Ford-Hutchinson
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 416-425;

  8. Becker, M W

    1. Thromboxane A2 stimulated signal transduction in vascular smooth muscle.
      G W Dorn and M W Becker
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 447-456;

  9. Bend, J R

    1. N-aralkyl derivatives of 1-aminobenzotriazole as potent isozyme-selective mechanism-based inhibitors of rabbit pulmonary cytochrome P450 in vivo.
      J M Mathews and J R Bend
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 281-285;

  10. Benjamin, C W

    1. 2-Aminochromones block human platelet aggregation by inhibiting cyclic AMP-dependent phosphodiesterase leading to reduced platelet phospholipase C activity.
      C W Benjamin, A H Lin, J Morris, D G Wishka and R R Gorman
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 457-462;

  11. Benloucif, S

    1. Serotonin-facilitated dopamine release in vivo: pharmacological characterization.
      S Benloucif, M J Keegan and M P Galloway
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 373-377;

  12. Berson, A

    1. Metabolic activation of the nitroaromatic antiandrogen flutamide by rat and human cytochromes P-450, including forms belonging to the 3A and 1A subfamilies.
      A Berson, C Wolf, C Chachaty, C Fisch, D Fau, D Eugene, J Loeper, J C Gauthier, P Beaune and D Pompon
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 366-372;

  13. Bertrand, C

    1. Neurogenic vasodilation in the rat nasal mucosa involves neurokinin1 tachykinin receptors.
      G Piedimonte, J I Hoffman, W K Husseini, C Bertrand, R M Snider, M C Desai, G Petersson and J A Nadel
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 36-40;

  14. Bian, K

    1. Antiproliferative and endothelium-dependent vasodilator properties of 1,3-dihydro-3-p-chlorophenyl-7-hydroxy-6-methyl-furo-(3,4c) pyridine hydrochloride (cicletanine).
      R D Bukoski, J Bo, H Xue and K Bian
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 30-35;

  15. Billings, B

    1. Opioid receptor regulation in mice.
      B C Yoburn, B Billings and A Duttaroy
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 314-320;

  16. Birkett, D J

    1. Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2.
      W Tassaneeyakul, D J Birkett, M E Veronese, M E McManus, R H Tukey, L C Quattrochi, H V Gelboin and J O Miners
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 401-407;

  17. Blier, P

    1. Differential properties of pre- and postsynaptic 5-hydroxytryptamine1A receptors in the dorsal raphe and hippocampus: II. Effect of pertussis and cholera toxins.
      P Blier, A Lista and C De Montigny
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 16-23;
    2. Differential properties of pre- and postsynaptic 5-hydroxytryptamine1A receptors in the dorsal raphe and hippocampus: I. Effect of spiperone.
      P Blier, A Lista and C De Montigny
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 7-15;

  18. Bo, J

    1. Antiproliferative and endothelium-dependent vasodilator properties of 1,3-dihydro-3-p-chlorophenyl-7-hydroxy-6-methyl-furo-(3,4c) pyridine hydrochloride (cicletanine).
      R D Bukoski, J Bo, H Xue and K Bian
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 30-35;

  19. Böhm, M

    1. Cardiac inotropic as well as coronary and pulmonary artery actions of epinine in human isolated tissues.
      R H Schwinger, M Böhm, C Schulz, U Schmidt, U Schmidt, B Schmid, H Dienemann, B Reichart and E Erdmann
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 346-357;

  20. Borroni, E

    1. Monoamine oxidase-A inhibitors and dopamine metabolism in rat caudatus: evidence that an increased cytosolic level of dopamine displaces reversible monoamine oxidase-A inhibitors in vivo.
      A Colzi, F D'Agostini, A M Cesura, E Borroni and M Da Prada
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 103-111;

  21. Brideau, C

    1. Leukotriene generation and metabolism in dogs: inhibition of biosynthesis by MK-0591.
      P Tagari, A Becker, C Brideau, R Frenette, V Sadl, E Thomas, P Vickers and A Ford-Hutchinson
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 416-425;

  22. Bueno, L

    1. Comparative action of Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2 analogs on intestinal motility and nociception in rats.
      M Million, J Fioramonti, S Gicquel, J M Zajac and L Bueno
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 96-102;

  23. Bukoski, R D

    1. Antiproliferative and endothelium-dependent vasodilator properties of 1,3-dihydro-3-p-chlorophenyl-7-hydroxy-6-methyl-furo-(3,4c) pyridine hydrochloride (cicletanine).
      R D Bukoski, J Bo, H Xue and K Bian
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 30-35;

  24. Burns, L A

    1. Reversal of gallium arsenide-induced suppression of the antibody-forming cell response by vehicle supernatants. I. Pharmacokinetics after in vitro and in vivo exposure.
      L A Burns and A E Munson
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 144-149;
    2. Reversal of gallium arsenide-induced suppression of the antibody-forming cell response by vehicle supernatants. II. Nature and identification of reversing factors.
      L A Burns and A E Munson
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 150-158;
    3. Gallium arsenide selectively inhibits T cell proliferation and alters expression of CD25 (IL-2R/p55).
      L A Burns and A E Munson
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 178-186;

C

  1. Cantrill, E

    1. Induction of cytochrome P450 2B1 in rat liver by the aromatase inhibitor aminoglutethimide.
      M Murray, E Cantrill and G C Farrell
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 477-481;

  2. Carpéné, C

    1. Desensitization of beta-1 and beta-2, but not beta-3, adrenoceptor-mediated lipolytic responses of adipocytes after long-term norepinephrine infusion.
      C Carpéné, J Galitzky, P Collon, F Esclapez, M Dauzats and M Lafontan
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 237-247;

  3. Cesura, A M

    1. Monoamine oxidase-A inhibitors and dopamine metabolism in rat caudatus: evidence that an increased cytosolic level of dopamine displaces reversible monoamine oxidase-A inhibitors in vivo.
      A Colzi, F D'Agostini, A M Cesura, E Borroni and M Da Prada
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 103-111;

  4. Chachaty, C

    1. Metabolic activation of the nitroaromatic antiandrogen flutamide by rat and human cytochromes P-450, including forms belonging to the 3A and 1A subfamilies.
      A Berson, C Wolf, C Chachaty, C Fisch, D Fau, D Eugene, J Loeper, J C Gauthier, P Beaune and D Pompon
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 366-372;

  5. Chang, S L

    1. Mu opiate receptor down-regulation by morphine and up-regulation by naloxone in SH-SY5Y human neuroblastoma cells.
      J E Zadina, S L Chang, L J Ge and A J Kastin
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 254-262;

  6. Chen, F Y

    1. Role of nitric oxide in neurogenic vasodilation of porcine cerebral artery.
      F Y Chen and T J Lee
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 339-345;

  7. Chen, J

    1. GM1 ganglioside treatment of focal ischemia: a dose-response and microdialysis study.
      R P Simon, J Chen and S H Graham
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 24-29;

  8. Churchill, P C

    1. Pharmacological characterization of the renovascular P2 purinergic receptors.
      P C Churchill and V R Ellis
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 334-338;

  9. Collon, P

    1. Desensitization of beta-1 and beta-2, but not beta-3, adrenoceptor-mediated lipolytic responses of adipocytes after long-term norepinephrine infusion.
      C Carpéné, J Galitzky, P Collon, F Esclapez, M Dauzats and M Lafontan
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 237-247;

  10. Colzi, A

    1. Monoamine oxidase-A inhibitors and dopamine metabolism in rat caudatus: evidence that an increased cytosolic level of dopamine displaces reversible monoamine oxidase-A inhibitors in vivo.
      A Colzi, F D'Agostini, A M Cesura, E Borroni and M Da Prada
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 103-111;

  11. Compton, D R

    1. Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities.
      D R Compton, K C Rice, B R De Costa, R K Razdan, L S Melvin, M R Johnson and B R Martin
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 218-226;

  12. Contrera, J G

    1. Muscarinic m2 receptors in cerebellar granule cell cultures from rat: mechanism of short-term desensitization.
      J G Contrera, S W Mcleskey, I Holopainen, J Xu and W J Wojcik
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 433-440;

  13. Cruz, S L

    1. Acute opioid dependence in the cardiovascular system of the spinal rat.
      S L Cruz and J E Villarreal
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 128-133;

D

  1. D'Agostini, F

    1. Monoamine oxidase-A inhibitors and dopamine metabolism in rat caudatus: evidence that an increased cytosolic level of dopamine displaces reversible monoamine oxidase-A inhibitors in vivo.
      A Colzi, F D'Agostini, A M Cesura, E Borroni and M Da Prada
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 103-111;

  2. Da Prada, M

    1. Monoamine oxidase-A inhibitors and dopamine metabolism in rat caudatus: evidence that an increased cytosolic level of dopamine displaces reversible monoamine oxidase-A inhibitors in vivo.
      A Colzi, F D'Agostini, A M Cesura, E Borroni and M Da Prada
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 103-111;

  3. Dauzats, M

    1. Desensitization of beta-1 and beta-2, but not beta-3, adrenoceptor-mediated lipolytic responses of adipocytes after long-term norepinephrine infusion.
      C Carpéné, J Galitzky, P Collon, F Esclapez, M Dauzats and M Lafontan
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 237-247;

  4. De Costa, B R

    1. Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities.
      D R Compton, K C Rice, B R De Costa, R K Razdan, L S Melvin, M R Johnson and B R Martin
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 218-226;

  5. de la Roza, G

    1. Induction of tolerance to crotoxin in mice.
      M Okamoto, L J Viskatis, G de la Roza and J C Vidal
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 41-46;

  6. Del Valle, J

    1. Epidermal growth factor and transforming growth factor-alpha directly inhibit parietal cell function through a similar mechanism.
      L Wang, M R Lucey, A M Fras, E J Wilson and J Del Valle
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 308-313;

  7. De Montigny, C

    1. Differential properties of pre- and postsynaptic 5-hydroxytryptamine1A receptors in the dorsal raphe and hippocampus: II. Effect of pertussis and cholera toxins.
      P Blier, A Lista and C De Montigny
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 16-23;
    2. Differential properties of pre- and postsynaptic 5-hydroxytryptamine1A receptors in the dorsal raphe and hippocampus: I. Effect of spiperone.
      P Blier, A Lista and C De Montigny
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 7-15;

  8. Desai, M C

    1. Neurogenic vasodilation in the rat nasal mucosa involves neurokinin1 tachykinin receptors.
      G Piedimonte, J I Hoffman, W K Husseini, C Bertrand, R M Snider, M C Desai, G Petersson and J A Nadel
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 36-40;

  9. Dibona, G F

    1. Central mu opioid receptor-mediated changes in renal function in conscious rats.
      D R Kapusta, J C Obih and G F Dibona
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 134-143;

  10. Dienemann, H

    1. Cardiac inotropic as well as coronary and pulmonary artery actions of epinine in human isolated tissues.
      R H Schwinger, M Böhm, C Schulz, U Schmidt, U Schmidt, B Schmid, H Dienemann, B Reichart and E Erdmann
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 346-357;

  11. Dinsdale, D

    1. Inhibition and induction of cytochrome P450 isoenzymes in rat lung.
      R D Verschoyle, D Dinsdale and C R Wolf
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 386-391;

  12. Dong, X

    1. Characterization of vascular postsynaptic neuropeptide Y receptor function and regulation. 1. NPY-induced constriction in isolated rat femoral artery rings is mediated by both Y1 and Y2 receptors: evidence from benextramine protection studies.
      R E Tessel, D W Miller, G A Misse, X Dong and M B Doughty
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 172-177;

  13. Dorn, G W

    1. Thromboxane A2 stimulated signal transduction in vascular smooth muscle.
      G W Dorn and M W Becker
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 447-456;

  14. Doughty, M B

    1. Characterization of vascular postsynaptic neuropeptide Y receptor function and regulation. 1. NPY-induced constriction in isolated rat femoral artery rings is mediated by both Y1 and Y2 receptors: evidence from benextramine protection studies.
      R E Tessel, D W Miller, G A Misse, X Dong and M B Doughty
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 172-177;

  15. Duttaroy, A

    1. Opioid receptor regulation in mice.
      B C Yoburn, B Billings and A Duttaroy
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 314-320;

E

  1. Ellis, V R

    1. Pharmacological characterization of the renovascular P2 purinergic receptors.
      P C Churchill and V R Ellis
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 334-338;

  2. Erdmann, E

    1. Cardiac inotropic as well as coronary and pulmonary artery actions of epinine in human isolated tissues.
      R H Schwinger, M Böhm, C Schulz, U Schmidt, U Schmidt, B Schmid, H Dienemann, B Reichart and E Erdmann
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 346-357;

  3. Esclapez, F

    1. Desensitization of beta-1 and beta-2, but not beta-3, adrenoceptor-mediated lipolytic responses of adipocytes after long-term norepinephrine infusion.
      C Carpéné, J Galitzky, P Collon, F Esclapez, M Dauzats and M Lafontan
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 237-247;

  4. Eskuri, S

    1. The volatile anesthetic isoflurane attenuates Ca++ mobilization in cultured vascular smooth muscle cells.
      J C Sill, S Eskuri, R Nelson, J Tarara and R A Van Dyke
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 74-80;

  5. Eugene, D

    1. Metabolic activation of the nitroaromatic antiandrogen flutamide by rat and human cytochromes P-450, including forms belonging to the 3A and 1A subfamilies.
      A Berson, C Wolf, C Chachaty, C Fisch, D Fau, D Eugene, J Loeper, J C Gauthier, P Beaune and D Pompon
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 366-372;

F

  1. Farrell, G C

    1. Induction of cytochrome P450 2B1 in rat liver by the aromatase inhibitor aminoglutethimide.
      M Murray, E Cantrill and G C Farrell
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 477-481;

  2. Fau, D

    1. Metabolic activation of the nitroaromatic antiandrogen flutamide by rat and human cytochromes P-450, including forms belonging to the 3A and 1A subfamilies.
      A Berson, C Wolf, C Chachaty, C Fisch, D Fau, D Eugene, J Loeper, J C Gauthier, P Beaune and D Pompon
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 366-372;

  3. Fioramonti, J

    1. Comparative action of Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2 analogs on intestinal motility and nociception in rats.
      M Million, J Fioramonti, S Gicquel, J M Zajac and L Bueno
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 96-102;

  4. Fisch, C

    1. Metabolic activation of the nitroaromatic antiandrogen flutamide by rat and human cytochromes P-450, including forms belonging to the 3A and 1A subfamilies.
      A Berson, C Wolf, C Chachaty, C Fisch, D Fau, D Eugene, J Loeper, J C Gauthier, P Beaune and D Pompon
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 366-372;

  5. Ford-Hutchinson, A

    1. Leukotriene generation and metabolism in dogs: inhibition of biosynthesis by MK-0591.
      P Tagari, A Becker, C Brideau, R Frenette, V Sadl, E Thomas, P Vickers and A Ford-Hutchinson
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 416-425;

  6. Fras, A M

    1. Epidermal growth factor and transforming growth factor-alpha directly inhibit parietal cell function through a similar mechanism.
      L Wang, M R Lucey, A M Fras, E J Wilson and J Del Valle
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 308-313;

  7. Frazer, M J

    1. Barbiturate anesthetics depress the resting K+ conductance of myocardium.
      J J Pancrazio, M J Frazer and C Lynch
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 358-365;

  8. Freier, D O

    1. Morphine-induced alterations in thymocyte subpopulations of B6C3F1 mice.
      D O Freier and B A Fuchs
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 81-88;

  9. Frenette, R

    1. Leukotriene generation and metabolism in dogs: inhibition of biosynthesis by MK-0591.
      P Tagari, A Becker, C Brideau, R Frenette, V Sadl, E Thomas, P Vickers and A Ford-Hutchinson
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 416-425;

  10. Freund, R K

    1. Sensitization of gamma-aminobutyric acid-induced depressions of cerebellar Purkinje neurons to the potentiative effects of ethanol by beta adrenergic mechanisms in rat brain.
      A M Lin, R K Freund and M R Palmer
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 426-432;

  11. Fuchs, B A

    1. Morphine-induced alterations in thymocyte subpopulations of B6C3F1 mice.
      D O Freier and B A Fuchs
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 81-88;

  12. Fukuhara, A

    1. An evaluation of an anti-inflammatory-histamine H2 antagonist drug complex on gastric erosions in the rat.
      T Imai, A Fukuhara, I Ueda and M Otagiri
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 328-333;

G

  1. Galitzky, J

    1. Desensitization of beta-1 and beta-2, but not beta-3, adrenoceptor-mediated lipolytic responses of adipocytes after long-term norepinephrine infusion.
      C Carpéné, J Galitzky, P Collon, F Esclapez, M Dauzats and M Lafontan
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 237-247;

  2. Galloway, M P

    1. Serotonin-facilitated dopamine release in vivo: pharmacological characterization.
      S Benloucif, M J Keegan and M P Galloway
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 373-377;

  3. Gauthier, J C

    1. Metabolic activation of the nitroaromatic antiandrogen flutamide by rat and human cytochromes P-450, including forms belonging to the 3A and 1A subfamilies.
      A Berson, C Wolf, C Chachaty, C Fisch, D Fau, D Eugene, J Loeper, J C Gauthier, P Beaune and D Pompon
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 366-372;

  4. Ge, L J

    1. Mu opiate receptor down-regulation by morphine and up-regulation by naloxone in SH-SY5Y human neuroblastoma cells.
      J E Zadina, S L Chang, L J Ge and A J Kastin
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 254-262;

  5. Gelboin, H V

    1. Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2.
      W Tassaneeyakul, D J Birkett, M E Veronese, M E McManus, R H Tukey, L C Quattrochi, H V Gelboin and J O Miners
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 401-407;

  6. Gemba, T

    1. Effects of a novel calcium antagonist, S-(+)-methyl-4,7-dihydro-3-isobutyl-6- methyl-4-(3-nitrophenyl)thieno[2,3-b]pyridine-5-carboxylate (S-312-d), on ischemic amino acid release and neuronal injury in stroke-prone spontaneously hypertensive rats.
      T Gemba, M Ninomiya, K Matsunaga and M Ueda
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 463-467;

  7. Gicquel, S

    1. Comparative action of Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2 analogs on intestinal motility and nociception in rats.
      M Million, J Fioramonti, S Gicquel, J M Zajac and L Bueno
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 96-102;

  8. Goldberg, S R

    1. Evaluation of the stereoisomers of deprenyl for amphetamine-like discriminative stimulus effects in rats.
      S Yasar, C W Schindler, E B Thorndike, I Szelenyi and S R Goldberg
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 1-6;

  9. Gorman, R R

    1. 2-Aminochromones block human platelet aggregation by inhibiting cyclic AMP-dependent phosphodiesterase leading to reduced platelet phospholipase C activity.
      C W Benjamin, A H Lin, J Morris, D G Wishka and R R Gorman
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 457-462;

  10. Goudreau, J L

    1. 5HT2 receptors mediate the effects of stress on the activity of periventricular hypophysial dopaminergic neurons and the secretion of alpha-melanocyte-stimulating hormone.
      J L Goudreau, J Manzanares, K J Lookingland and K E Moore
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 303-307;

  11. Graham, S H

    1. GM1 ganglioside treatment of focal ischemia: a dose-response and microdialysis study.
      R P Simon, J Chen and S H Graham
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 24-29;

  12. Griffiths, R R

    1. Behavioral effects of pentobarbital, lorazepam, ethanol and chlorpromazine substitution in pentobarbital-dependent baboons.
      R J Lamb and R R Griffiths
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 47-52;

  13. Guyenet, P G

    1. Respiratory control of sympathetic nerve activity during naloxone-precipitated morphine withdrawal in rats.
      S C Baraban, R L Stornetta and P G Guyenet
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 89-95;

H

  1. Hamann, S R

    1. Pharmacologic characteristics of a medullary hyperalgesic center.
      S Parvini, S R Hamann and W R Martin
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 286-293;

  2. Herman, B

    1. Mitochondrial and glycolytic dysfunction in lethal injury to hepatocytes by t-butylhydroperoxide: protection by fructose, cyclosporin A and trifluoperazine.
      R Imberti, A L Nieminen, B Herman and J J Lemasters
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 392-400;

  3. Herz, A

    1. Examination of the neurochemical substrates mediating the motivational effects of opioids: role of the mesolimbic dopamine system and D-1 vs. D-2 dopamine receptors.
      T S Shippenberg, R Bals-Kubik and A Herz
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 53-59;

  4. Hoffman, J I

    1. Neurogenic vasodilation in the rat nasal mucosa involves neurokinin1 tachykinin receptors.
      G Piedimonte, J I Hoffman, W K Husseini, C Bertrand, R M Snider, M C Desai, G Petersson and J A Nadel
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 36-40;

  5. Holopainen, I

    1. Muscarinic m2 receptors in cerebellar granule cell cultures from rat: mechanism of short-term desensitization.
      J G Contrera, S W Mcleskey, I Holopainen, J Xu and W J Wojcik
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 433-440;

  6. Hornby, P J

    1. Serotonin microinjected into the nucleus raphe obscurus increases intragastric pressure in the rat via a vagally mediated pathway.
      Z K Krowicki and P J Hornby
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 468-476;

  7. Hudzik, T J

    1. Effects of drugs of abuse and cholinergic agents on delayed matching-to-sample responding in the squirrel monkey.
      T J Hudzik and G R Wenger
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 120-127;

  8. Husseini, W K

    1. Neurogenic vasodilation in the rat nasal mucosa involves neurokinin1 tachykinin receptors.
      G Piedimonte, J I Hoffman, W K Husseini, C Bertrand, R M Snider, M C Desai, G Petersson and J A Nadel
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 36-40;

I

  1. Imai, T

    1. An evaluation of an anti-inflammatory-histamine H2 antagonist drug complex on gastric erosions in the rat.
      T Imai, A Fukuhara, I Ueda and M Otagiri
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 328-333;

  2. Imberti, R

    1. Mitochondrial and glycolytic dysfunction in lethal injury to hepatocytes by t-butylhydroperoxide: protection by fructose, cyclosporin A and trifluoperazine.
      R Imberti, A L Nieminen, B Herman and J J Lemasters
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 392-400;

J

  1. Johnson, M R

    1. Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities.
      D R Compton, K C Rice, B R De Costa, R K Razdan, L S Melvin, M R Johnson and B R Martin
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 218-226;

  2. Joyce, J N

    1. Serotonergic involvement in haloperidol-induced catalepsy.
      B S Neal-Beliveau, J N Joyce and I Lucki
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 207-217;

K

  1. Kachel, D L

    1. Mechanism of putrescine transport in human pulmonary artery endothelial cells.
      P P Sokol, K L Longenecker, D L Kachel and W J Martin
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 60-66;

  2. Kapusta, D R

    1. Central mu opioid receptor-mediated changes in renal function in conscious rats.
      D R Kapusta, J C Obih and G F Dibona
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 134-143;

  3. Kastin, A J

    1. Mu opiate receptor down-regulation by morphine and up-regulation by naloxone in SH-SY5Y human neuroblastoma cells.
      J E Zadina, S L Chang, L J Ge and A J Kastin
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 254-262;

  4. Keegan, M J

    1. Serotonin-facilitated dopamine release in vivo: pharmacological characterization.
      S Benloucif, M J Keegan and M P Galloway
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 373-377;

  5. Krowicki, Z K

    1. Serotonin microinjected into the nucleus raphe obscurus increases intragastric pressure in the rat via a vagally mediated pathway.
      Z K Krowicki and P J Hornby
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 468-476;

L

  1. Lafontan, M

    1. Desensitization of beta-1 and beta-2, but not beta-3, adrenoceptor-mediated lipolytic responses of adipocytes after long-term norepinephrine infusion.
      C Carpéné, J Galitzky, P Collon, F Esclapez, M Dauzats and M Lafontan
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 237-247;

  2. Lamb, R J

    1. Behavioral effects of pentobarbital, lorazepam, ethanol and chlorpromazine substitution in pentobarbital-dependent baboons.
      R J Lamb and R R Griffiths
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 47-52;

  3. Larson, A A

    1. Modulation of kainic acid-induced activity in the mouse spinal cord by the amino terminus of substance P: sensitivity to opioid antagonists.
      A A Larson and X Sun
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 159-165;

  4. Lee, T J

    1. Role of nitric oxide in neurogenic vasodilation of porcine cerebral artery.
      F Y Chen and T J Lee
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 339-345;

  5. Lemasters, J J

    1. Mitochondrial and glycolytic dysfunction in lethal injury to hepatocytes by t-butylhydroperoxide: protection by fructose, cyclosporin A and trifluoperazine.
      R Imberti, A L Nieminen, B Herman and J J Lemasters
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 392-400;

  6. Lin, A H

    1. 2-Aminochromones block human platelet aggregation by inhibiting cyclic AMP-dependent phosphodiesterase leading to reduced platelet phospholipase C activity.
      C W Benjamin, A H Lin, J Morris, D G Wishka and R R Gorman
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 457-462;

  7. Lin, A M

    1. Sensitization of gamma-aminobutyric acid-induced depressions of cerebellar Purkinje neurons to the potentiative effects of ethanol by beta adrenergic mechanisms in rat brain.
      A M Lin, R K Freund and M R Palmer
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 426-432;

  8. Lista, A

    1. Differential properties of pre- and postsynaptic 5-hydroxytryptamine1A receptors in the dorsal raphe and hippocampus: II. Effect of pertussis and cholera toxins.
      P Blier, A Lista and C De Montigny
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 16-23;
    2. Differential properties of pre- and postsynaptic 5-hydroxytryptamine1A receptors in the dorsal raphe and hippocampus: I. Effect of spiperone.
      P Blier, A Lista and C De Montigny
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 7-15;

  9. Loeper, J

    1. Metabolic activation of the nitroaromatic antiandrogen flutamide by rat and human cytochromes P-450, including forms belonging to the 3A and 1A subfamilies.
      A Berson, C Wolf, C Chachaty, C Fisch, D Fau, D Eugene, J Loeper, J C Gauthier, P Beaune and D Pompon
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 366-372;

  10. Longenecker, K L

    1. Mechanism of putrescine transport in human pulmonary artery endothelial cells.
      P P Sokol, K L Longenecker, D L Kachel and W J Martin
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 60-66;

  11. Longone, P

    1. Characterization of a decrease in muscarinic m2 mRNA in cerebellar granule cells by carbachol.
      P Longone, I Mocchetti, M A Riva and W J Wojcik
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 441-446;

  12. Lookingland, K J

    1. 5HT2 receptors mediate the effects of stress on the activity of periventricular hypophysial dopaminergic neurons and the secretion of alpha-melanocyte-stimulating hormone.
      J L Goudreau, J Manzanares, K J Lookingland and K E Moore
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 303-307;

  13. Lucey, M R

    1. Epidermal growth factor and transforming growth factor-alpha directly inhibit parietal cell function through a similar mechanism.
      L Wang, M R Lucey, A M Fras, E J Wilson and J Del Valle
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 308-313;

  14. Lucki, I

    1. Serotonergic involvement in haloperidol-induced catalepsy.
      B S Neal-Beliveau, J N Joyce and I Lucki
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 207-217;
    2. Somatostatin receptors in the nucleus accumbens selectively mediate the stimulatory effect of somatostatin on locomotor activity in rats.
      K Raynor, I Lucki and T Reisine
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 67-73;

  15. Lukas, R J

    1. Expression of ganglia-type nicotinic acetylcholine receptors and nicotinic ligand binding sites by cells of the IMR-32 human neuroblastoma clonal line.
      R J Lukas
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 294-302;

  16. Lynch, C

    1. Barbiturate anesthetics depress the resting K+ conductance of myocardium.
      J J Pancrazio, M J Frazer and C Lynch
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 358-365;

M

  1. Macherey, H J

    1. Secretin and somatostatin as modulators of electrolyte transport in guinea pig gallbladder epithelium.
      G Sprakties, H J Macherey and K U Petersen
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 273-280;

  2. Major, T C

    1. Effects of quinapril, a new angiotensin-converting enzyme inhibitor, on vasoconstrictor activity in the isolated, perfused mesenteric vasculature of hypertensive rats.
      T C Major, R W Overhiser, D G Taylor and R L Panek
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 187-193;

  3. Manzanares, J

    1. 5HT2 receptors mediate the effects of stress on the activity of periventricular hypophysial dopaminergic neurons and the secretion of alpha-melanocyte-stimulating hormone.
      J L Goudreau, J Manzanares, K J Lookingland and K E Moore
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 303-307;

  4. Martin, B J

    1. Chronic physical activity alters hepatobiliary excretory function in rats.
      C A Yiamouyiannis, B J Martin and J B Watkins
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 321-327;

  5. Martin, B R

    1. Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities.
      D R Compton, K C Rice, B R De Costa, R K Razdan, L S Melvin, M R Johnson and B R Martin
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 218-226;

  6. Martin, P L

    1. (+-)-N6-endonorbornan-2-yl-9-methyladenine (N-0861) and its enantiomers: selective antagonists of A1-adenosine receptors in guinea pig isolated atria.
      P L Martin, A A Potts, A M Sykes and D G McKenna
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 201-206;
    2. In vitro and in vivo pharmacological characterization of N6-cyclopentyl-9-methyladenine (N-0840): a selective, orally active A1 adenosine receptor antagonist.
      R J Barrett, J M May, P L Martin and J R Miller
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 227-236;
    3. 2-Phenylethoxy-9-methyladenine: an adenosine receptor antagonist that discriminates between A2 adenosine receptors in the aorta and the coronary vessels from the guinea pig.
      P L Martin, M Ueeda and R A Olsson
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 248-253;

  7. Martin, W J

    1. Mechanism of putrescine transport in human pulmonary artery endothelial cells.
      P P Sokol, K L Longenecker, D L Kachel and W J Martin
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 60-66;

  8. Martin, W R

    1. Pharmacologic characteristics of a medullary hyperalgesic center.
      S Parvini, S R Hamann and W R Martin
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 286-293;

  9. Mathews, J M

    1. N-aralkyl derivatives of 1-aminobenzotriazole as potent isozyme-selective mechanism-based inhibitors of rabbit pulmonary cytochrome P450 in vivo.
      J M Mathews and J R Bend
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 281-285;

  10. Matsunaga, K

    1. Effects of a novel calcium antagonist, S-(+)-methyl-4,7-dihydro-3-isobutyl-6- methyl-4-(3-nitrophenyl)thieno[2,3-b]pyridine-5-carboxylate (S-312-d), on ischemic amino acid release and neuronal injury in stroke-prone spontaneously hypertensive rats.
      T Gemba, M Ninomiya, K Matsunaga and M Ueda
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 463-467;

  11. May, J M

    1. In vitro and in vivo pharmacological characterization of N6-cyclopentyl-9-methyladenine (N-0840): a selective, orally active A1 adenosine receptor antagonist.
      R J Barrett, J M May, P L Martin and J R Miller
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 227-236;

  12. McKenna, D G

    1. (+-)-N6-endonorbornan-2-yl-9-methyladenine (N-0861) and its enantiomers: selective antagonists of A1-adenosine receptors in guinea pig isolated atria.
      P L Martin, A A Potts, A M Sykes and D G McKenna
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 201-206;

  13. Mcleskey, S W

    1. Muscarinic m2 receptors in cerebellar granule cell cultures from rat: mechanism of short-term desensitization.
      J G Contrera, S W Mcleskey, I Holopainen, J Xu and W J Wojcik
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 433-440;

  14. McManus, M E

    1. Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2.
      W Tassaneeyakul, D J Birkett, M E Veronese, M E McManus, R H Tukey, L C Quattrochi, H V Gelboin and J O Miners
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 401-407;

  15. Melvin, L S

    1. Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities.
      D R Compton, K C Rice, B R De Costa, R K Razdan, L S Melvin, M R Johnson and B R Martin
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 218-226;

  16. Miller, D W

    1. Characterization of vascular postsynaptic neuropeptide Y receptor function and regulation. 1. NPY-induced constriction in isolated rat femoral artery rings is mediated by both Y1 and Y2 receptors: evidence from benextramine protection studies.
      R E Tessel, D W Miller, G A Misse, X Dong and M B Doughty
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 172-177;

  17. Miller, J R

    1. In vitro and in vivo pharmacological characterization of N6-cyclopentyl-9-methyladenine (N-0840): a selective, orally active A1 adenosine receptor antagonist.
      R J Barrett, J M May, P L Martin and J R Miller
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 227-236;

  18. Million, M

    1. Comparative action of Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2 analogs on intestinal motility and nociception in rats.
      M Million, J Fioramonti, S Gicquel, J M Zajac and L Bueno
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 96-102;

  19. Miners, J O

    1. Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2.
      W Tassaneeyakul, D J Birkett, M E Veronese, M E McManus, R H Tukey, L C Quattrochi, H V Gelboin and J O Miners
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 401-407;

  20. Misse, G A

    1. Characterization of vascular postsynaptic neuropeptide Y receptor function and regulation. 1. NPY-induced constriction in isolated rat femoral artery rings is mediated by both Y1 and Y2 receptors: evidence from benextramine protection studies.
      R E Tessel, D W Miller, G A Misse, X Dong and M B Doughty
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 172-177;

  21. Mocchetti, I

    1. Characterization of a decrease in muscarinic m2 mRNA in cerebellar granule cells by carbachol.
      P Longone, I Mocchetti, M A Riva and W J Wojcik
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 441-446;

  22. Moore, K E

    1. 5HT2 receptors mediate the effects of stress on the activity of periventricular hypophysial dopaminergic neurons and the secretion of alpha-melanocyte-stimulating hormone.
      J L Goudreau, J Manzanares, K J Lookingland and K E Moore
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 303-307;

  23. Morris, J

    1. 2-Aminochromones block human platelet aggregation by inhibiting cyclic AMP-dependent phosphodiesterase leading to reduced platelet phospholipase C activity.
      C W Benjamin, A H Lin, J Morris, D G Wishka and R R Gorman
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 457-462;

  24. Munson, A E

    1. Reversal of gallium arsenide-induced suppression of the antibody-forming cell response by vehicle supernatants. I. Pharmacokinetics after in vitro and in vivo exposure.
      L A Burns and A E Munson
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 144-149;
    2. Reversal of gallium arsenide-induced suppression of the antibody-forming cell response by vehicle supernatants. II. Nature and identification of reversing factors.
      L A Burns and A E Munson
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 150-158;
    3. Gallium arsenide selectively inhibits T cell proliferation and alters expression of CD25 (IL-2R/p55).
      L A Burns and A E Munson
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 178-186;

  25. Murray, M

    1. Induction of cytochrome P450 2B1 in rat liver by the aromatase inhibitor aminoglutethimide.
      M Murray, E Cantrill and G C Farrell
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 477-481;

N

  1. Nadel, J A

    1. Neurogenic vasodilation in the rat nasal mucosa involves neurokinin1 tachykinin receptors.
      G Piedimonte, J I Hoffman, W K Husseini, C Bertrand, R M Snider, M C Desai, G Petersson and J A Nadel
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 36-40;

  2. Neal-Beliveau, B S

    1. Serotonergic involvement in haloperidol-induced catalepsy.
      B S Neal-Beliveau, J N Joyce and I Lucki
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 207-217;

  3. Nejat, R J

    1. Independent expression of two pharmacologically distinct supraspinal mu analgesic systems in genetically different mouse strains.
      C G Pick, R J Nejat and G W Pasternak
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 166-171;

  4. Nelson, R

    1. The volatile anesthetic isoflurane attenuates Ca++ mobilization in cultured vascular smooth muscle cells.
      J C Sill, S Eskuri, R Nelson, J Tarara and R A Van Dyke
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 74-80;

  5. Nieminen, A L

    1. Mitochondrial and glycolytic dysfunction in lethal injury to hepatocytes by t-butylhydroperoxide: protection by fructose, cyclosporin A and trifluoperazine.
      R Imberti, A L Nieminen, B Herman and J J Lemasters
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 392-400;

  6. Ninomiya, M

    1. Effects of a novel calcium antagonist, S-(+)-methyl-4,7-dihydro-3-isobutyl-6- methyl-4-(3-nitrophenyl)thieno[2,3-b]pyridine-5-carboxylate (S-312-d), on ischemic amino acid release and neuronal injury in stroke-prone spontaneously hypertensive rats.
      T Gemba, M Ninomiya, K Matsunaga and M Ueda
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 463-467;

O

  1. Obih, J C

    1. Central mu opioid receptor-mediated changes in renal function in conscious rats.
      D R Kapusta, J C Obih and G F Dibona
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 134-143;

  2. Okamoto, M

    1. Induction of tolerance to crotoxin in mice.
      M Okamoto, L J Viskatis, G de la Roza and J C Vidal
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 41-46;

  3. Olsson, R A

    1. 2-Phenylethoxy-9-methyladenine: an adenosine receptor antagonist that discriminates between A2 adenosine receptors in the aorta and the coronary vessels from the guinea pig.
      P L Martin, M Ueeda and R A Olsson
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 248-253;

  4. Otagiri, M

    1. An evaluation of an anti-inflammatory-histamine H2 antagonist drug complex on gastric erosions in the rat.
      T Imai, A Fukuhara, I Ueda and M Otagiri
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 328-333;

  5. Overhiser, R W

    1. Effects of quinapril, a new angiotensin-converting enzyme inhibitor, on vasoconstrictor activity in the isolated, perfused mesenteric vasculature of hypertensive rats.
      T C Major, R W Overhiser, D G Taylor and R L Panek
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 187-193;

P

  1. Palmer, M R

    1. Sensitization of gamma-aminobutyric acid-induced depressions of cerebellar Purkinje neurons to the potentiative effects of ethanol by beta adrenergic mechanisms in rat brain.
      A M Lin, R K Freund and M R Palmer
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 426-432;

  2. Pancrazio, J J

    1. Barbiturate anesthetics depress the resting K+ conductance of myocardium.
      J J Pancrazio, M J Frazer and C Lynch
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 358-365;

  3. Panek, R L

    1. Effects of quinapril, a new angiotensin-converting enzyme inhibitor, on vasoconstrictor activity in the isolated, perfused mesenteric vasculature of hypertensive rats.
      T C Major, R W Overhiser, D G Taylor and R L Panek
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 187-193;

  4. Pang, C C

    1. In vitro and ex vivo inhibitory effects of L- and D-enantiomers of NG-nitro-arginine on endothelium-dependent relaxation of rat aorta.
      Y X Wang, C I Poon and C C Pang
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 112-119;
    2. Functional integrity of the central and sympathetic nervous systems is a prerequisite for pressor and tachycardic effects of diphenyleneiodonium, a novel inhibitor of nitric oxide synthase.
      Y X Wang and C C Pang
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 263-272;

  5. Parvini, S

    1. Pharmacologic characteristics of a medullary hyperalgesic center.
      S Parvini, S R Hamann and W R Martin
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 286-293;

  6. Pasternak, G W

    1. Independent expression of two pharmacologically distinct supraspinal mu analgesic systems in genetically different mouse strains.
      C G Pick, R J Nejat and G W Pasternak
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 166-171;

  7. Petersen, K U

    1. Secretin and somatostatin as modulators of electrolyte transport in guinea pig gallbladder epithelium.
      G Sprakties, H J Macherey and K U Petersen
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 273-280;

  8. Petersson, G

    1. Neurogenic vasodilation in the rat nasal mucosa involves neurokinin1 tachykinin receptors.
      G Piedimonte, J I Hoffman, W K Husseini, C Bertrand, R M Snider, M C Desai, G Petersson and J A Nadel
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 36-40;

  9. Pick, C G

    1. Independent expression of two pharmacologically distinct supraspinal mu analgesic systems in genetically different mouse strains.
      C G Pick, R J Nejat and G W Pasternak
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 166-171;

  10. Piedimonte, G

    1. Neurogenic vasodilation in the rat nasal mucosa involves neurokinin1 tachykinin receptors.
      G Piedimonte, J I Hoffman, W K Husseini, C Bertrand, R M Snider, M C Desai, G Petersson and J A Nadel
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 36-40;

  11. Polosa, C

    1. Mechanism of the bradycardia produced in the cat by the anticholinesterase neostigmine.
      S B Backman, M Bachoo and C Polosa
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 194-200;

  12. Pompon, D

    1. Metabolic activation of the nitroaromatic antiandrogen flutamide by rat and human cytochromes P-450, including forms belonging to the 3A and 1A subfamilies.
      A Berson, C Wolf, C Chachaty, C Fisch, D Fau, D Eugene, J Loeper, J C Gauthier, P Beaune and D Pompon
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 366-372;

  13. Poon, C I

    1. In vitro and ex vivo inhibitory effects of L- and D-enantiomers of NG-nitro-arginine on endothelium-dependent relaxation of rat aorta.
      Y X Wang, C I Poon and C C Pang
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 112-119;

  14. Potts, A A

    1. (+-)-N6-endonorbornan-2-yl-9-methyladenine (N-0861) and its enantiomers: selective antagonists of A1-adenosine receptors in guinea pig isolated atria.
      P L Martin, A A Potts, A M Sykes and D G McKenna
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 201-206;

Q

  1. Quattrochi, L C

    1. Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2.
      W Tassaneeyakul, D J Birkett, M E Veronese, M E McManus, R H Tukey, L C Quattrochi, H V Gelboin and J O Miners
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 401-407;

R

  1. Raynor, K

    1. Somatostatin receptors in the nucleus accumbens selectively mediate the stimulatory effect of somatostatin on locomotor activity in rats.
      K Raynor, I Lucki and T Reisine
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 67-73;

  2. Razdan, R K

    1. Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities.
      D R Compton, K C Rice, B R De Costa, R K Razdan, L S Melvin, M R Johnson and B R Martin
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 218-226;

  3. Reichart, B

    1. Cardiac inotropic as well as coronary and pulmonary artery actions of epinine in human isolated tissues.
      R H Schwinger, M Böhm, C Schulz, U Schmidt, U Schmidt, B Schmid, H Dienemann, B Reichart and E Erdmann
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 346-357;

  4. Reisine, T

    1. Somatostatin receptors in the nucleus accumbens selectively mediate the stimulatory effect of somatostatin on locomotor activity in rats.
      K Raynor, I Lucki and T Reisine
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 67-73;

  5. Rice, K C

    1. Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities.
      D R Compton, K C Rice, B R De Costa, R K Razdan, L S Melvin, M R Johnson and B R Martin
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 218-226;

  6. Riva, M A

    1. Characterization of a decrease in muscarinic m2 mRNA in cerebellar granule cells by carbachol.
      P Longone, I Mocchetti, M A Riva and W J Wojcik
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 441-446;

  7. Rosebrough, S F

    1. Plasma stability and pharmacokinetics of radiolabeled deferoxamine-biotin derivatives.
      S F Rosebrough
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 408-415;

S

  1. Sadl, V

    1. Leukotriene generation and metabolism in dogs: inhibition of biosynthesis by MK-0591.
      P Tagari, A Becker, C Brideau, R Frenette, V Sadl, E Thomas, P Vickers and A Ford-Hutchinson
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 416-425;

  2. Schindler, C W

    1. Evaluation of the stereoisomers of deprenyl for amphetamine-like discriminative stimulus effects in rats.
      S Yasar, C W Schindler, E B Thorndike, I Szelenyi and S R Goldberg
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 1-6;

  3. Schmid, B

    1. Cardiac inotropic as well as coronary and pulmonary artery actions of epinine in human isolated tissues.
      R H Schwinger, M Böhm, C Schulz, U Schmidt, U Schmidt, B Schmid, H Dienemann, B Reichart and E Erdmann
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 346-357;

  4. Schmidt, U

    1. Cardiac inotropic as well as coronary and pulmonary artery actions of epinine in human isolated tissues.
      R H Schwinger, M Böhm, C Schulz, U Schmidt, U Schmidt, B Schmid, H Dienemann, B Reichart and E Erdmann
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 346-357;
    2. Cardiac inotropic as well as coronary and pulmonary artery actions of epinine in human isolated tissues.
      R H Schwinger, M Böhm, C Schulz, U Schmidt, U Schmidt, B Schmid, H Dienemann, B Reichart and E Erdmann
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 346-357;

  5. Schulz, C

    1. Cardiac inotropic as well as coronary and pulmonary artery actions of epinine in human isolated tissues.
      R H Schwinger, M Böhm, C Schulz, U Schmidt, U Schmidt, B Schmid, H Dienemann, B Reichart and E Erdmann
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 346-357;

  6. Schwinger, R H

    1. Cardiac inotropic as well as coronary and pulmonary artery actions of epinine in human isolated tissues.
      R H Schwinger, M Böhm, C Schulz, U Schmidt, U Schmidt, B Schmid, H Dienemann, B Reichart and E Erdmann
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 346-357;

  7. Shippenberg, T S

    1. Examination of the neurochemical substrates mediating the motivational effects of opioids: role of the mesolimbic dopamine system and D-1 vs. D-2 dopamine receptors.
      T S Shippenberg, R Bals-Kubik and A Herz
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 53-59;

  8. Sill, J C

    1. The volatile anesthetic isoflurane attenuates Ca++ mobilization in cultured vascular smooth muscle cells.
      J C Sill, S Eskuri, R Nelson, J Tarara and R A Van Dyke
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 74-80;

  9. Simon, R P

    1. GM1 ganglioside treatment of focal ischemia: a dose-response and microdialysis study.
      R P Simon, J Chen and S H Graham
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 24-29;

  10. Snider, R M

    1. Neurogenic vasodilation in the rat nasal mucosa involves neurokinin1 tachykinin receptors.
      G Piedimonte, J I Hoffman, W K Husseini, C Bertrand, R M Snider, M C Desai, G Petersson and J A Nadel
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 36-40;

  11. Sokol, P P

    1. Mechanism of putrescine transport in human pulmonary artery endothelial cells.
      P P Sokol, K L Longenecker, D L Kachel and W J Martin
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 60-66;

  12. Sprakties, G

    1. Secretin and somatostatin as modulators of electrolyte transport in guinea pig gallbladder epithelium.
      G Sprakties, H J Macherey and K U Petersen
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 273-280;

  13. Stornetta, R L

    1. Respiratory control of sympathetic nerve activity during naloxone-precipitated morphine withdrawal in rats.
      S C Baraban, R L Stornetta and P G Guyenet
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 89-95;

  14. Sun, X

    1. Modulation of kainic acid-induced activity in the mouse spinal cord by the amino terminus of substance P: sensitivity to opioid antagonists.
      A A Larson and X Sun
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 159-165;

  15. Sykes, A M

    1. (+-)-N6-endonorbornan-2-yl-9-methyladenine (N-0861) and its enantiomers: selective antagonists of A1-adenosine receptors in guinea pig isolated atria.
      P L Martin, A A Potts, A M Sykes and D G McKenna
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 201-206;

  16. Szelenyi, I

    1. Evaluation of the stereoisomers of deprenyl for amphetamine-like discriminative stimulus effects in rats.
      S Yasar, C W Schindler, E B Thorndike, I Szelenyi and S R Goldberg
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 1-6;

T

  1. Tagari, P

    1. Leukotriene generation and metabolism in dogs: inhibition of biosynthesis by MK-0591.
      P Tagari, A Becker, C Brideau, R Frenette, V Sadl, E Thomas, P Vickers and A Ford-Hutchinson
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 416-425;

  2. Tarara, J

    1. The volatile anesthetic isoflurane attenuates Ca++ mobilization in cultured vascular smooth muscle cells.
      J C Sill, S Eskuri, R Nelson, J Tarara and R A Van Dyke
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 74-80;

  3. Tassaneeyakul, W

    1. Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2.
      W Tassaneeyakul, D J Birkett, M E Veronese, M E McManus, R H Tukey, L C Quattrochi, H V Gelboin and J O Miners
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 401-407;

  4. Taylor, D G

    1. Effects of quinapril, a new angiotensin-converting enzyme inhibitor, on vasoconstrictor activity in the isolated, perfused mesenteric vasculature of hypertensive rats.
      T C Major, R W Overhiser, D G Taylor and R L Panek
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 187-193;

  5. Tessel, R E

    1. Characterization of vascular postsynaptic neuropeptide Y receptor function and regulation. 1. NPY-induced constriction in isolated rat femoral artery rings is mediated by both Y1 and Y2 receptors: evidence from benextramine protection studies.
      R E Tessel, D W Miller, G A Misse, X Dong and M B Doughty
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 172-177;

  6. Thomas, E

    1. Leukotriene generation and metabolism in dogs: inhibition of biosynthesis by MK-0591.
      P Tagari, A Becker, C Brideau, R Frenette, V Sadl, E Thomas, P Vickers and A Ford-Hutchinson
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 416-425;

  7. Thorndike, E B

    1. Evaluation of the stereoisomers of deprenyl for amphetamine-like discriminative stimulus effects in rats.
      S Yasar, C W Schindler, E B Thorndike, I Szelenyi and S R Goldberg
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 1-6;

  8. Tukey, R H

    1. Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2.
      W Tassaneeyakul, D J Birkett, M E Veronese, M E McManus, R H Tukey, L C Quattrochi, H V Gelboin and J O Miners
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 401-407;

U

  1. Ueda, I

    1. An evaluation of an anti-inflammatory-histamine H2 antagonist drug complex on gastric erosions in the rat.
      T Imai, A Fukuhara, I Ueda and M Otagiri
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 328-333;

  2. Ueda, M

    1. Effects of a novel calcium antagonist, S-(+)-methyl-4,7-dihydro-3-isobutyl-6- methyl-4-(3-nitrophenyl)thieno[2,3-b]pyridine-5-carboxylate (S-312-d), on ischemic amino acid release and neuronal injury in stroke-prone spontaneously hypertensive rats.
      T Gemba, M Ninomiya, K Matsunaga and M Ueda
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 463-467;

  3. Ueeda, M

    1. 2-Phenylethoxy-9-methyladenine: an adenosine receptor antagonist that discriminates between A2 adenosine receptors in the aorta and the coronary vessels from the guinea pig.
      P L Martin, M Ueeda and R A Olsson
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 248-253;

V

  1. Van Dyke, R A

    1. The volatile anesthetic isoflurane attenuates Ca++ mobilization in cultured vascular smooth muscle cells.
      J C Sill, S Eskuri, R Nelson, J Tarara and R A Van Dyke
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 74-80;

  2. Veronese, M E

    1. Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2.
      W Tassaneeyakul, D J Birkett, M E Veronese, M E McManus, R H Tukey, L C Quattrochi, H V Gelboin and J O Miners
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 401-407;

  3. Verschoyle, R D

    1. Inhibition and induction of cytochrome P450 isoenzymes in rat lung.
      R D Verschoyle, D Dinsdale and C R Wolf
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 386-391;

  4. Vickers, P

    1. Leukotriene generation and metabolism in dogs: inhibition of biosynthesis by MK-0591.
      P Tagari, A Becker, C Brideau, R Frenette, V Sadl, E Thomas, P Vickers and A Ford-Hutchinson
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 416-425;

  5. Vidal, J C

    1. Induction of tolerance to crotoxin in mice.
      M Okamoto, L J Viskatis, G de la Roza and J C Vidal
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 41-46;

  6. Villarreal, J E

    1. Acute opioid dependence in the cardiovascular system of the spinal rat.
      S L Cruz and J E Villarreal
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 128-133;

  7. Viskatis, L J

    1. Induction of tolerance to crotoxin in mice.
      M Okamoto, L J Viskatis, G de la Roza and J C Vidal
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 41-46;

W

  1. Wang, L

    1. Epidermal growth factor and transforming growth factor-alpha directly inhibit parietal cell function through a similar mechanism.
      L Wang, M R Lucey, A M Fras, E J Wilson and J Del Valle
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 308-313;

  2. Wang, Y X

    1. In vitro and ex vivo inhibitory effects of L- and D-enantiomers of NG-nitro-arginine on endothelium-dependent relaxation of rat aorta.
      Y X Wang, C I Poon and C C Pang
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 112-119;
    2. Functional integrity of the central and sympathetic nervous systems is a prerequisite for pressor and tachycardic effects of diphenyleneiodonium, a novel inhibitor of nitric oxide synthase.
      Y X Wang and C C Pang
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 263-272;

  3. Watkins, J B

    1. Chronic physical activity alters hepatobiliary excretory function in rats.
      C A Yiamouyiannis, B J Martin and J B Watkins
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 321-327;

  4. Wenger, G R

    1. Effects of drugs of abuse and cholinergic agents on delayed matching-to-sample responding in the squirrel monkey.
      T J Hudzik and G R Wenger
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 120-127;

  5. Wilcox, G L

    1. Differential roles of 5-hydroxytryptamine1A and 5-hydroxytryptamine1B receptor subtypes in modulating spinal nociceptive transmission in mice.
      A A Alhaider and G L Wilcox
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 378-385;

  6. Wilson, E J

    1. Epidermal growth factor and transforming growth factor-alpha directly inhibit parietal cell function through a similar mechanism.
      L Wang, M R Lucey, A M Fras, E J Wilson and J Del Valle
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 308-313;

  7. Wishka, D G

    1. 2-Aminochromones block human platelet aggregation by inhibiting cyclic AMP-dependent phosphodiesterase leading to reduced platelet phospholipase C activity.
      C W Benjamin, A H Lin, J Morris, D G Wishka and R R Gorman
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 457-462;

  8. Wojcik, W J

    1. Muscarinic m2 receptors in cerebellar granule cell cultures from rat: mechanism of short-term desensitization.
      J G Contrera, S W Mcleskey, I Holopainen, J Xu and W J Wojcik
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 433-440;
    2. Characterization of a decrease in muscarinic m2 mRNA in cerebellar granule cells by carbachol.
      P Longone, I Mocchetti, M A Riva and W J Wojcik
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 441-446;

  9. Wolf, C

    1. Metabolic activation of the nitroaromatic antiandrogen flutamide by rat and human cytochromes P-450, including forms belonging to the 3A and 1A subfamilies.
      A Berson, C Wolf, C Chachaty, C Fisch, D Fau, D Eugene, J Loeper, J C Gauthier, P Beaune and D Pompon
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 366-372;

  10. Wolf, C R

    1. Inhibition and induction of cytochrome P450 isoenzymes in rat lung.
      R D Verschoyle, D Dinsdale and C R Wolf
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 386-391;

X

  1. Xu, J

    1. Muscarinic m2 receptors in cerebellar granule cell cultures from rat: mechanism of short-term desensitization.
      J G Contrera, S W Mcleskey, I Holopainen, J Xu and W J Wojcik
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 433-440;

  2. Xue, H

    1. Antiproliferative and endothelium-dependent vasodilator properties of 1,3-dihydro-3-p-chlorophenyl-7-hydroxy-6-methyl-furo-(3,4c) pyridine hydrochloride (cicletanine).
      R D Bukoski, J Bo, H Xue and K Bian
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 30-35;

Y

  1. Yasar, S

    1. Evaluation of the stereoisomers of deprenyl for amphetamine-like discriminative stimulus effects in rats.
      S Yasar, C W Schindler, E B Thorndike, I Szelenyi and S R Goldberg
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 1-6;

  2. Yiamouyiannis, C A

    1. Chronic physical activity alters hepatobiliary excretory function in rats.
      C A Yiamouyiannis, B J Martin and J B Watkins
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 321-327;

  3. Yoburn, B C

    1. Opioid receptor regulation in mice.
      B C Yoburn, B Billings and A Duttaroy
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 314-320;

Z

  1. Zadina, J E

    1. Mu opiate receptor down-regulation by morphine and up-regulation by naloxone in SH-SY5Y human neuroblastoma cells.
      J E Zadina, S L Chang, L J Ge and A J Kastin
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 254-262;

  2. Zajac, J M

    1. Comparative action of Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2 analogs on intestinal motility and nociception in rats.
      M Million, J Fioramonti, S Gicquel, J M Zajac and L Bueno
      Journal of Pharmacology and Experimental Therapeutics April 1993, 265 (1) 96-102;
Back to top

In this issue